{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:17:43Z","timestamp":1790687863403,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.vaccine.2004.03.042","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T12:30:11Z","timestamp":1082723411000},"page":"3563-3574","source":"Crossref","is-referenced-by-count":51,"title":["Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine"],"prefix":"10.1016","volume":"22","author":[{"given":"Bruno","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornthep","family":"Chanthavanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukiat","family":"Sirivichayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Sabchareon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Begue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutee","family":"Yoksan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Luxemburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.03.042_BIB1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00001432-200210000-00003","volume":"15","author":"Halstead","year":"2002","journal-title":"Dengue. Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2004.03.042_BIB3","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","article-title":"Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.03.042_BIB6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB7","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1099\/0022-1317-71-12-2909","article-title":"Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies","volume":"71","author":"Morens D","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S0022172400070923","article-title":"Immunological enhancement and the pathogenesis of dengue haemorrhagic fever","volume":"89","author":"Porterfield","year":"1982","journal-title":"J. Hyg. (Lond.)"},{"key":"10.1016\/j.vaccine.2004.03.042_BIB9","first-page":"46","article-title":"Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic?","volume":"80","author":"Papaevangelou","year":"1977","journal-title":"J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S1020-49892002000400003","article-title":"Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks","volume":"11","author":"Guzman","year":"2002","journal-title":"Rev. Panam. Salud. Publica."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1999.9656","article-title":"Immunopathogenesis of dengue hemorrhagic fever","volume":"257","author":"Rothman","year":"1999","journal-title":"Virology"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2004.03.042_BIB12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0264-410X(00)00040-2","article-title":"Live attenuated tetravalent dengue vaccine","volume":"18","author":"Bhamarapravati","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.042_BIB13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2002.66.264","article-title":"Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses","volume":"66","author":"Sabchareon","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.inf.0000109289.55856.27","article-title":"Safety and immunogenicity of a three dose regimen of two tetravalent live attenuated dengue vaccines in 5\u201312 year old Thai children","volume":"23","author":"Sabchareon","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.03.042_BIB15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2003.68.191","article-title":"Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999","volume":"68","author":"Nisalak","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/77553","article-title":"Human skin Langerhans cells are targets of dengue virus infection","volume":"6","author":"Wu","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB17","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","article-title":"Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection","volume":"144","author":"Littaua","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4269\/ajtmh.2002.67.102","article-title":"Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes","volume":"67","author":"Loke","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/viro.1999.9816","article-title":"Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus","volume":"260","author":"Schlesinger","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.03.042_BIB20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.03.042_BIB21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat. Med."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T12:46:02Z","timestamp":1682685962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04002932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":21,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0264410X04002932"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.03.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}